Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Emily Chan

2 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Basic Science

    VICCGI15122

    01/15/2016

    Research Use of Human Biospecimens from Colorectal Cancer Patients (Pilot Study)

    Treatment

    VICCPHI1616

    06/08/2016

    A Phase 1 Open-Label Study of the Safety, Tolerability and Efficacy of KPT-9274, a Dual Inhibitor of PAK4 and NAMPT, in Patients with Advanced Solid Malignancies or Non-Hodgkin's Lymphoma


    Print this page for your doctor